HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients.

AuthorsValerio Ricci, Massimiliano Pomponi, Giovanni Martinotti, Annarita Bentivoglio, Giovanna Loria, Sergio Bernardini, Carlo Caltagirone, Pietro Bria, Francesco Angelucci
JournalJournal of clinical psychopharmacology (J Clin Psychopharmacol) Vol. 30 Issue 6 Pg. 751-3 (Dec 2010) ISSN: 1533-712X [Electronic] United States
PMID21057246 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antidepressive Agents
  • Antiparkinson Agents
  • Brain-Derived Neurotrophic Factor
  • GDNF protein, human
  • Glial Cell Line-Derived Neurotrophic Factor
  • Serotonin Uptake Inhibitors
Topics
  • Antidepressive Agents (pharmacology, therapeutic use)
  • Antiparkinson Agents (therapeutic use)
  • Brain-Derived Neurotrophic Factor (blood, drug effects)
  • Case-Control Studies
  • Depression (complications, drug therapy)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Glial Cell Line-Derived Neurotrophic Factor (blood)
  • Humans
  • Male
  • Parkinson Disease (complications, drug therapy)
  • Selective Serotonin Reuptake Inhibitors (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: